Correlation Between AptaBio Therapeutics and Shinhan Inverse

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AptaBio Therapeutics and Shinhan Inverse at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AptaBio Therapeutics and Shinhan Inverse into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AptaBio Therapeutics and Shinhan Inverse Silver, you can compare the effects of market volatilities on AptaBio Therapeutics and Shinhan Inverse and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AptaBio Therapeutics with a short position of Shinhan Inverse. Check out your portfolio center. Please also check ongoing floating volatility patterns of AptaBio Therapeutics and Shinhan Inverse.

Diversification Opportunities for AptaBio Therapeutics and Shinhan Inverse

-0.02
  Correlation Coefficient

Good diversification

The 3 months correlation between AptaBio and Shinhan is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding AptaBio Therapeutics and Shinhan Inverse Silver in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shinhan Inverse Silver and AptaBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AptaBio Therapeutics are associated (or correlated) with Shinhan Inverse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shinhan Inverse Silver has no effect on the direction of AptaBio Therapeutics i.e., AptaBio Therapeutics and Shinhan Inverse go up and down completely randomly.

Pair Corralation between AptaBio Therapeutics and Shinhan Inverse

Assuming the 90 days trading horizon AptaBio Therapeutics is expected to under-perform the Shinhan Inverse. In addition to that, AptaBio Therapeutics is 1.82 times more volatile than Shinhan Inverse Silver. It trades about -0.19 of its total potential returns per unit of risk. Shinhan Inverse Silver is currently generating about -0.05 per unit of volatility. If you would invest  393,000  in Shinhan Inverse Silver on September 4, 2024 and sell it today you would lose (30,000) from holding Shinhan Inverse Silver or give up 7.63% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy96.61%
ValuesDaily Returns

AptaBio Therapeutics  vs.  Shinhan Inverse Silver

 Performance 
       Timeline  
AptaBio Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AptaBio Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Shinhan Inverse Silver 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Shinhan Inverse Silver has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

AptaBio Therapeutics and Shinhan Inverse Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AptaBio Therapeutics and Shinhan Inverse

The main advantage of trading using opposite AptaBio Therapeutics and Shinhan Inverse positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AptaBio Therapeutics position performs unexpectedly, Shinhan Inverse can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shinhan Inverse will offset losses from the drop in Shinhan Inverse's long position.
The idea behind AptaBio Therapeutics and Shinhan Inverse Silver pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Transaction History
View history of all your transactions and understand their impact on performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk